QUADRANT CAPITAL GROUP LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$106,578
+10.7%
2,790
+4.6%
0.01%
+10.0%
Q2 2023$96,235
+143.7%
2,668
+158.0%
0.01%
+150.0%
Q1 2023$39,489
-27.7%
1,034
+7.7%
0.00%
-33.3%
Q4 2022$54,624
+203.5%
960
+111.5%
0.01%
+200.0%
Q3 2022$18,000
-10.0%
454
+0.4%
0.00%
-33.3%
Q2 2022$20,000
+42.9%
452
+25.9%
0.00%
+50.0%
Q1 2022$14,000
+55.6%
359
+56.1%
0.00%
+100.0%
Q4 2021$9,000
+50.0%
230
+46.5%
0.00%0.0%
Q3 2021$6,0000.0%157
+26.6%
0.00%0.0%
Q2 2021$6,000
+20.0%
124
+2.5%
0.00%0.0%
Q1 2021$5,0000.0%121
+12.0%
0.00%0.0%
Q4 2020$5,000
+66.7%
1080.0%0.00%0.0%
Q3 2020$3,0000.0%108
+14.9%
0.00%0.0%
Q2 2020$3,000
-91.7%
94
-95.4%
0.00%
-83.3%
Q1 2020$36,000
+2.9%
2,053
+0.5%
0.01%
+50.0%
Q4 2019$35,000
+483.3%
2,042
+476.8%
0.00%0.0%
Q4 2015$6,0003540.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders